BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 14629126)

  • 1. Efficacy and safety of rush immunotherapy in patients with Hymenoptera allergy in Japan.
    Hirata H; Asakura T; Arima M; Cheng G; Honda K; Fukushima F; Yamaguchi B; Yoshida N; Fukuda T
    Asian Pac J Allergy Immunol; 2003 Jun; 21(2):89-94. PubMed ID: 14629126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rush hymenoptera venom immunotherapy is efficacious and safe.
    Pasaoglu G; Sin BA; Misirligil Z
    J Investig Allergol Clin Immunol; 2006; 16(4):232-8. PubMed ID: 16889280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rush immunotherapy for wasp venom allergy seems safe and effective in patients with mastocytosis.
    Verburg M; Oldhoff JM; Klemans RJ; Lahey-de Boer A; de Bruin-Weller MS; Röckmann H; Sanders C; Bruijnzeel-Koomen CA; Pasmans SG; Knulst AC
    Eur Ann Allergy Clin Immunol; 2015 Nov; 47(6):192-6. PubMed ID: 26549336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-dependent sting recurrence and outcome in immunotherapy-treated children with anaphylaxis to Hymenoptera venom.
    Stritzke AI; Eng PA
    Clin Exp Allergy; 2013 Aug; 43(8):950-5. PubMed ID: 23889248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hymenoptera stings.
    Fitzgerald KT; Flood AA
    Clin Tech Small Anim Pract; 2006 Nov; 21(4):194-204. PubMed ID: 17265905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Insect sting allergy--clinical aspects, diagnosis and therapy].
    Müller U
    Wien Med Wochenschr; 1989 Apr; 139(6-7):150-6. PubMed ID: 2658345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venom immunotherapy in patients with allergic reactions to insect stings.
    Incorvaia C; Mauro M; Gritti BL; Makri E; Ridolo E
    Expert Rev Clin Immunol; 2018 Jan; 14(1):53-59. PubMed ID: 29202591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insect sting allergy.
    McLean DC
    Prim Care; 1987 Sep; 14(3):513-21. PubMed ID: 3671581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple 3-day "rush" venom immunotherapy protocol: documentation of safety.
    Kalogeromitros D; Makris M; Koti I; Chliva C; Mellios A; Avgerinou G; Theoharides TC
    Allergol Immunopathol (Madr); 2010; 38(2):69-73. PubMed ID: 19853357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of venom immunotherapy on serum level of CCL5/RANTES in patients with Hymenoptera venom allergy.
    Gawlik R; Glück J; Jawor B; Rogala B
    Immunopharmacol Immunotoxicol; 2015; 37(4):375-9. PubMed ID: 26181651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hymenoptera venom allergy in humans.
    Cichocka-Jarosz E
    Folia Med Cracov; 2012; 52(3-4):43-60. PubMed ID: 24852686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rush hyposensitization with Hymenoptera venoms. Tolerance and results of therapy].
    Przybilla B; Ring J; Griesshammer B; Braun-Falco O
    Dtsch Med Wochenschr; 1987 Mar; 112(11):416-24. PubMed ID: 3816590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of Hymenoptera venom allergy.
    Biló BM; Rueff F; Mosbech H; Bonifazi F; Oude-Elberink JN;
    Allergy; 2005 Nov; 60(11):1339-49. PubMed ID: 16197464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Side effects of specific immunotherapy in patients with hymenoptera venom allergy].
    Lata J; Specjalski K; Kołaczkowska M; Chełmińska M; Niedoszytko M; Jassem E
    Pneumonol Alergol Pol; 2005; 73(3):260-3. PubMed ID: 16989163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of safety, risk factors and pretreatment methods during rush hymenoptera venom immunotherapy.
    Gorska L; Chelminska M; Kuziemski K; Skrzypski M; Niedoszytko M; Damps-Konstanska I; Szymanowska A; Siemińska A; Wajda B; Drozdowska A; Jutel M; Jassem E
    Int Arch Allergy Immunol; 2008; 147(3):241-5. PubMed ID: 18594155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mastocytosis and insect venom allergy.
    Bonadonna P; Zanotti R; Müller U
    Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):347-53. PubMed ID: 20485157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of rush immunotherapy (RIT) on Hymenoptera allergy].
    Hirata H; Yukawa T; Arima M; Yamada G; Makino S; Fukuda T
    Arerugi; 1999 Dec; 48(12):1331-6. PubMed ID: 10666921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insect Venom Immunotherapy: Analysis of the Safety and Tolerance of 3 Buildup Protocols Frequently Used in Spain.
    Gutiérrez Fernández D; Moreno-Ancillo A; Fernández Meléndez S; Domínguez-Noche C; Gálvez Ruiz P; Alfaya Arias T; Carballada González F; Alonso Llamazares A; Marques Amat L; Vega Castro A; Antolín Amérigo D; Cruz Granados S; Ruiz León B; Sánchez Morillas L; Fernández Sánchez J; Soriano Gomis V; Borja Segade J; Dalmau Duch G; Guspi Bori R; Miranda Páez A
    J Investig Allergol Clin Immunol; 2016; 26(6):366-373. PubMed ID: 27996943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hymenoptera ultra-rush venom immunotherapy (210 min): a safety study and risk factors.
    Birnbaum J; Ramadour M; Magnan A; Vervloet D
    Clin Exp Allergy; 2003 Jan; 33(1):58-64. PubMed ID: 12534550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic and local reactions of bee venom immunotherapy in Iran.
    Bemanian MH; Farhoudi A; Pourpak Z; Gharagozlou M; Movahedi M; Nabavi M; Mozafari H; Mohammadzadeh I; Chavoshzadeh Z; Shirkhoda Z
    Iran J Allergy Asthma Immunol; 2007 Dec; 6(4):203-6. PubMed ID: 18094443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.